D-Index & Metrics Best Publications

Marco Cicardi

University of Milan
Italy

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 78 Citations 18,766 352 World Ranking 13030 National Ranking 465

Overview

What is he best known for?

The fields of study Marco Cicardi is best known for:

Inflammation
Antibody
Bradykinin

As part of his studies on Internal medicine, Marco Cicardi frequently links adjacent subjects like Retrospective cohort study. His Immunology study frequently links to adjacent areas such as Cryoglobulins. Many of his studies on Cryoglobulins involve topics that are commonly interrelated, such as Immunology. He performs integrative study on Angioedema and Allergy. Marco Cicardi incorporates Allergy and Angioedema in his research. Marco Cicardi performs integrative study on Antibody and Autoantibody. While working on this project, he studies both Autoantibody and Antibody. His Dermatology study frequently links to adjacent areas such as Hereditary angioedema. In his study, Marco Cicardi carries out multidisciplinary Hereditary angioedema and C1-inhibitor research.

His most cited work include:

Acquired C1-Inhibitor Deficiency Associated with Antiidiotypic Antibody to Monoclonal Immunoglobulins (163 citations)
New topics in bradykinin research (142 citations)
Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema (96 citations)

What are the main themes of his work throughout his whole career to date

The study of Internal medicine is intertwined with the study of Coagulation in a number of ways. With his scientific publications, his incorporates both Angioedema and C1-inhibitor. Marco Cicardi conducts interdisciplinary study in the fields of C1-inhibitor and Hereditary angioedema through his research. Marco Cicardi conducted interdisciplinary study in his works that combined Hereditary angioedema and Angioedema. He applies his multidisciplinary studies on Immunology and Pathology in his research. Marco Cicardi incorporates Pathology and Immunology in his studies. Dermatology and Gastroenterology are two areas of study in which Marco Cicardi engages in interdisciplinary research. His work often combines Gastroenterology and Internal medicine studies. Much of his study explores Biochemistry relationship to Kallikrein.

Marco Cicardi most often published in these fields:

Internal medicine (68.57%)
Angioedema (65.71%)
Hereditary angioedema (51.43%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.

Angelo Agostoni;Emel Aygören-Pürsün;Karen E. Binkley;Alvaro Blanch.
The Journal of Allergy and Clinical Immunology (2004)

822 Citations

Plasma bradykinin in angio-oedema

Juerg Nussberger;Massimo Cugno;Catherine Amstutz;Marco Cicardi.
The Lancet (1998)

803 Citations

Hereditary and Acquired C1-inhibitor Deficiency: Biological and Clinical Characteristics in 235 Patients

Angelo Agostoni;Marco Cicardi.
Medicine (1992)

756 Citations

Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

Marco Cicardi;W. Aberer;A. Banerji;M. Bas.
Allergy (2014)

625 Citations

2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema

Tom Bowen;Marco Cicardi;Henriette Farkas;Konrad Bork.
Allergy, Asthma & Clinical Immunology (2004)

613 Citations

Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema

Marco Cicardi;Aleena Banerji;Francisco Bracho;Alejandro Malbrán.
The New England Journal of Medicine (2010)

574 Citations

Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group

M. Cicardi;K. Bork;T. Caballero;T. Craig.
Allergy (2012)

426 Citations

Ecallantide for the treatment of acute attacks in hereditary angioedema.

Marco Cicardi;Robyn J. Levy;Donald L. McNeil;H. Henry Li.
The New England Journal of Medicine (2010)

344 Citations

Hereditary angio-oedema

Hilary Longhurst;Marco Cicardi.
The Lancet (2012)

343 Citations

C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress.

Massimo Cugno;Andrea Zanichelli;Fabrizio Foieni;Sonia Caccia.
Trends in Molecular Medicine (2009)

309 Citations

If you think any of the details on this page are incorrect, let us know.